RankingsPricing
  1. US-listed companies
  2. GLOBUS MEDICAL INC
  3. Financials
  4. Stock-based compensation

GLOBUS MEDICAL INCGMED

Market cap
$11.9B
P/E ratio
SummaryFinancials
Period EndStock-based compensation (Million USD)YoY (%)
Dec 31, 202454+2.75%
Dec 31, 202353+60.75%
Dec 31, 202233+7.27%
Dec 31, 202131+12.98%
Dec 31, 202027+3.79%
Dec 31, 201926+19.12%
Dec 31, 201822+49.11%
Dec 31, 201715+29.03%
Dec 31, 201611+18.08%
Dec 31, 201510+35.55%
Dec 31, 20147+37.36%
Dec 31, 20135+11.69%
Dec 31, 20125

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)